Let’s face it—picking up a prescription at the pharmacy is a grim experience. You have to travel to a pharmacy, wait in line, overhear the personal information of the customer at the next register, and then share your own personal data. To make matters worse, your prescription is out of stock or requires more time (that frankly, you don’t have) to fill.
Consumers aren’t the only ones who suffer: 25% of doctors’ time is spent on pharmacy-related issues that would otherwise go to spending more time with their patients.
Our health is precious and so is our time and privacy. By reimagining the consumer experience from the ground up, Capsule has built a better, more delightful experience for all constituents. Capsule offers free delivery wherever you are within two hours, the ability to chat, text, or call a pharmacist, and a simple, easy-to-use app that allows you to manage all your medications on your phone. Bonus: Capsule also handles everything with your insurance.
To date, Capsule has had incredible traction and growth in New York City, where the brand is ubiquitous and the product is loved. We believe the pain point that exists in NYC is also felt across the country and strongly believe that the pharmacy market will undergo a secular shift from offline to online (currently under 1%), similar to furniture (currently 17% online) and grocery (3% online). This secular shift will have a major impact on the $350 billion U.S. addressable market (i.e. $350 billion pain point for consumers!), and Capsule is well-positioned to win it by taking its playbook honed in NYC to major cities across the U.S.
M13 is committed to backing companies that improve the daily lives of consumers through technology, and Capsule is doing exactly that. We are so excited to partner with Eric Kinariwala and his team and join fellow investors TCV, Thrive Capital, Glade Brook Capital Partners, and Virgin Group to scale their vision.
Let’s face it—picking up a prescription at the pharmacy is a grim experience. You have to travel to a pharmacy, wait in line, overhear the personal information of the customer at the next register, and then share your own personal data. To make matters worse, your prescription is out of stock or requires more time (that frankly, you don’t have) to fill.
Consumers aren’t the only ones who suffer: 25% of doctors’ time is spent on pharmacy-related issues that would otherwise go to spending more time with their patients.
Our health is precious and so is our time and privacy. By reimagining the consumer experience from the ground up, Capsule has built a better, more delightful experience for all constituents. Capsule offers free delivery wherever you are within two hours, the ability to chat, text, or call a pharmacist, and a simple, easy-to-use app that allows you to manage all your medications on your phone. Bonus: Capsule also handles everything with your insurance.
To date, Capsule has had incredible traction and growth in New York City, where the brand is ubiquitous and the product is loved. We believe the pain point that exists in NYC is also felt across the country and strongly believe that the pharmacy market will undergo a secular shift from offline to online (currently under 1%), similar to furniture (currently 17% online) and grocery (3% online). This secular shift will have a major impact on the $350 billion U.S. addressable market (i.e. $350 billion pain point for consumers!), and Capsule is well-positioned to win it by taking its playbook honed in NYC to major cities across the U.S.
M13 is committed to backing companies that improve the daily lives of consumers through technology, and Capsule is doing exactly that. We are so excited to partner with Eric Kinariwala and his team and join fellow investors TCV, Thrive Capital, Glade Brook Capital Partners, and Virgin Group to scale their vision.
Read more
The views expressed here are those of the individual M13 personnel quoted and are not the views of M13 Holdings Company, LLC (“M13”) or its affiliates. This content is for general informational purposes only and does not and is not intended to constitute legal, business, investment, tax or other advice. You should consult your own advisers as to those matters and should not act or refrain from acting on the basis of this content. This content is not directed to any investors or potential investors, is not an offer or solicitation and may not be used or relied upon in connection with any offer or solicitation with respect to any current or future M13 investment partnership. Past performance is not indicative of future results. Unless otherwise noted, this content is intended to be current only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in funds managed by M13, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by M13 is available at m13.co/portfolio.